Medicine and Dentistry
Depressive Disorder
100%
Meta-Analysis
81%
Probiotics
81%
Cost-Effectiveness Analysis
81%
Treatment Resistant Depression
81%
Quetiapine
81%
Randomized Controlled Trial
50%
Gut
40%
Systematic Review
40%
Health Care Cost
27%
Antidepressant
26%
Adverse Event
18%
Gut Microbiota
12%
Technology Assessment
9%
Hamilton Rating Scale for Depression
9%
Bipolar Disorder
9%
Personal Experience
9%
DSM-5
9%
Health Technology
9%
Symptomatology
9%
National Health Service
9%
Intention-to-Treat Analysis
9%
Major Depressive Episode
9%
C Reactive Protein
8%
Antidepressant Activity
8%
Brain Derived Neurotrophic Factor
8%
Controlled Clinical Trial
8%
Mental Disorder
8%
Pharmacology, Toxicology and Pharmaceutical Science
Depressive Disorder
100%
Quetiapine
81%
Treatment Resistant Depression
81%
Antidepressant
63%
Randomized Controlled Trial
50%
Intestine Flora
27%
Adverse Event
18%
Bifidobacterium
13%
Lactobacillus
13%
Random Effects Model
13%
Controlled Clinical Trial
13%
Population Study
13%
Brain Derived Neurotrophic Factor
13%
C Reactive Protein
13%
Tolerability
13%
Combination Therapy
13%
Major Depression
9%
Symptomatology
9%
DSM-5
9%
Bipolar Disorder
9%
Toxic Injury
9%
Nursing and Health Professions
Treatment Resistant Depression
81%
Quetiapine
81%
Cost Effectiveness Analysis
81%
Depressive Disorder
18%
Randomization
18%
Adverse Event
18%
Economic Analysis
9%
Socialized Medicine
9%
Intention to Treat Analysis
9%
Biomedical Technology Assessment
9%
Lived Experience
9%
Hamilton Depression Rating Scale
9%
DSM-5
9%
Symptomatology
9%
Antidepressant
9%
Bipolar Disorder
9%
Major Depression
9%
